Article List

WPRIM Management System> DCMS> Acta Pharmaceutica Sinica> 2009> 44> 3

Volume: 44 Issue: 3

1. Synthesis and cardioprotective effect of a novel anti-ischemic/reperfused injury compound.	Page:321—326
2. Comparative pharmacophore analysis of dual dopamine D2/5-HT(2A) receptor antagonists.	Page:314—320
3. A novel cell model targeted on GLP-1 receptor for application to anti-diabetic candidates screening.	Page:309—313
4. Design, synthesis and 5-HT/NE dual reuptake inhibitory activity of aromatic heterocyclic arylamidine derivatives.	Page:303—308
5. Synergic effects of the combination of VEGF-targeted shRNA and taxol on human prostate cancer DU145 both in vitro and in vivo.	Page:296—302
6. The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.	Page:288—295
7. The multi-target drugs and their design.	Page:282—287
8. Design of multiple targeted drugs.	Page:276—281
9. Thoughts and experimental exploration on pharmacokinetic study of herbal medicines with multiple-components and targets.	Page:270—275
10. Recent advance in the study of novel anti-tumor targets and drugs--aurora kinase and Pin1.	Page:264—269
11. Progress in the research on multi-target-directed drugs against Alzheimer's disease.	Page:258—263
12. The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase III.	Page:242—257
13. Controlling arachidonic acid metabolic network: from single- to multi-target inhibitors of key enzymes.	Page:231—241
14. Multi-target therapeutics and new drug discovery.	Page:226—230
15. Small interfering RNA mediated multi-target therapy of cancer.	Page:219—225
16. Strategy of molecular drug design: dual-target drug design.	Page:209—218